About Thryv Therapeutics Inc.
Transforming the treatment of inherited arrhythmias and cardiometabolic diseases.
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Montreal, Quebec
- Founded
- 2019
- Company type
- Privately Held
Thryv Therapeutics Inc. is a clinical-stage biotech pioneering precision medicine approaches to treating genetic arrhythmia syndromes and acquired cardiometabolic diseases through potent and highly selective inhibitors of serum glucocorticoid inducible kinase 1 (SGK1). For more information, please visit www.thryvtrx.com.
Company locations
999 Boulevard De Maisonneuve Ouest, Montreal, Quebec, CA
Locations listed on the company profile. These may include offices outside Canada, and not every location is hiring.
On LinkedIn
- Followers
- 4,505
- People linked to this company
- 34
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.